Published online Nov 7, 2024. doi: 10.3748/wjg.v30.i41.4411
Revised: September 26, 2024
Accepted: October 11, 2024
Published online: November 7, 2024
Processing time: 179 Days and 2.6 Hours
Core Tip: This editorial encapsulates pivotal research and breakthroughs in inflammatory bowel disease (IBD) treatment, suggesting a comprehensive and integrated approach. It highlights intestinal microecology enhancement, the application of computational methods for drug discovery, dual biologic therapy use, and the integration of telemedicine. Additionally, a discussion of emerging concerns, such as the effects of the coronavirus disease 2019 pandemic, mental health challenges, and bowel preparation strategies in IBD care, illustrates the importance of addressing these interconnected aspects for holistic patient management. There remains a necessity for collaborative, innovative treatment strategies that leverage cross-disciplinary insights to advance care in IBD patients.
